Obstructive sleep apnea affects roughly a quarter of adults worldwide, and the number is climbing. Its cognitive toll is well documented: deficits in attention, executive function, spatial memory, working memory, and situational memory. But the mechanism has never been fully explained. Prior research focused on inflammation, oxidative stress, and apoptosis in the hippocampus, but it largely left out a key variable: the neurotransmitters that actually drive memory.
A new narrative review from Peking University Third Hospital, published in the World Journal of Otorhinolaryngology Head and Neck Surgery, pulls the missing thread. Authors Rui Fan, Tao Li, and Yan Yan argue that hippocampal dopamine depletion is the common denominator linking sleep fragmentation and chronic intermittent hypoxia to memory loss in OSA patients.
The review identifies three parallel pathways through which sleep-disordered breathing damages the hippocampus, plus a fourth mechanism involving chronic intermittent hypoxia that creates a self-reinforcing cycle of dopamine decline.
Pathway One: Inflammation
Sleep deprivation and sleep fragmentation drive up pro-inflammatory cytokines in the hippocampus, specifically IL-1B, TNF-alpha, and TGF-B. The evidence is striking: direct injection of IL-1B into the hippocampus causes concentration-dependent memory impairment in animal models. TNF-alpha suppresses long-term potentiation in the CA1 region, a cellular process essential for memory formation.
Dopamine intervenes at a critical junction. When dopamine binds to its receptors on microglia, it inhibits lipopolysaccharide-induced microglial activation and nitric oxide production through D1-like receptors, modulating ERK and NF-kB signaling. Dopamine supplementation reduces TNF-alpha and IL-1B levels and prevents the resulting memory deficits. Conversely, sleep deprivation reduces hippocampal dopamine, and dopamine receptor agonists reverse the deprivation-induced memory impairments.
Pathway Two: Oxidative Stress
Sleep fragmentation increases lipid peroxidation and malondialdehyde in hippocampal tissue while decreasing the antioxidant enzymes superoxide dismutase and glutathione peroxidase.
Dopamine plays a complex dual role here. Through D4 receptors, it provides receptor-mediated protection. Independently of receptors, it functions as an intrinsic antioxidant. The catch is homeostasis. Both elevated and depleted dopamine can trigger oxidative stress. Without a concurrent stressor, dopamine receptor agonists and antagonists alike disrupt dopamine balance and cause oxidative damage. But when a stressor such as sleep fragmentation is present, dopamine supplementation becomes protective rather than harmful.
This bifacial pharmacology helps explain why the dopamine system in the hippocampus is so tightly regulated and why its disruption in OSA has disproportionate consequences.
Pathway Three: Apoptosis
Sleep deprivation shifts the hippocampus toward programmed cell death. It upregulates the pro-apoptotic proteins Bax and cleaved caspase-3 while downregulating the anti-apoptotic protein Bcl-2.
The transcription factor CREB sits at the center of this pathway. Sleep deprivation downregulates both CREB expression and its phosphorylation, promoting apoptosis. Dopamine receptor activation reverses these deprivation-induced reductions in CREB phosphorylation. The upstream signaling failures are extensive: downregulation of ERK in the MAPK pathway, upregulation of PDE impairing PKA signaling, reduced CaMK IV, and reduced PI3K, AKT, and GSK-3B signaling. Each converges on the Bcl-2, Bax, and caspase-3 cascade. Dopamine receptor agonists such as SKF38393 restore these pathways, demonstrating that dopamine sits upstream of the cell death machinery.
The CIH Feedback Loop
Chronic intermittent hypoxia, the hallmark of OSA, produces a more complex pattern of dopamine dysregulation than simple sleep loss. Studies using microdialysis show that CIH decreases extracellular dopamine in the striatum. Yet total dopamine measured in cell homogenates is actually increased in the frontal cortex and medulla, and PC-12 cells in vitro show increased intracellular dopamine under hypoxic conditions.
The mechanism behind this paradox reveals a feedback loop. CIH upregulates VMAT-2 and increases tyrosine hydroxylase phosphorylation through PKA and CaMK signaling, while downregulating PP2A. More dopamine is synthesized and stored intracellularly, but less is released. Extracellular dopamine drops. Reduced D2 dopamine receptor binding leads to even less PP2A inhibition, creating a positive cycle of further TH activation without corresponding release. Meanwhile, less extracellular dopamine means less D1 receptor activation on immune cells, reducing PKA and CaMK signaling, driving dopamine further down. The system locks into a downward spiral.
Why It Matters
The review opens two concrete clinical avenues. First, exercise emerges as a practical dopamine-boosting adjunct to continuous positive airway pressure. Physical activity increases hippocampal dopamine release, potentially counteracting the depletion caused by both sleep fragmentation and CIH. Second, dopamine-sensitive PET imaging could serve as an early biomarker for hippocampal vulnerability in OSA patients, identifying those most at risk for cognitive decline before structural damage appears.
The therapeutic implication is that treating OSA with CPAP alone may be necessary but not sufficient for preserving memory function. Targeting the dopamine axis directly, whether through exercise, pharmacology, or both, could close the gap left by mechanical ventilation.
Limits
As a narrative review, this paper synthesizes existing animal and human data rather than presenting new experimental results. Much of the mechanistic detail comes from rodent models, and the human evidence for hippocampal dopamine depletion in OSA remains indirect. The dual role of dopamine in oxidative stress means that therapeutic interventions will need precise calibration, and the field lacks clinical trials that test dopamine-targeted strategies specifically in OSA patients with cognitive complaints.
Source
Fan R, Li T, Yan Y. Mechanism of cognitive impairment induced by obstructive sleep apnea from the perspective of hippocampal dopamine. World J Otorhinolaryngol Head Neck Surg. 2026 Jan 28. DOI: 10.1002/wjo2.70077. PMCID: PMC13398938. PMID: 42500070.